Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Rita Dr Phil Hoffmann is active.

Publication


Featured researches published by Rita Dr Phil Hoffmann.


Zentralblatt für Bakteriologie, Mikrobiologie, und Hygiene | 1985

Investigations on the Bactericidal Activity of Fosfomycin Using the Membrane Filter-Agar Dilution Method and the Time-Kill Technique

Rainer Haag; Rita Dr Phil Hoffmann

Minimum inhibitory concentrations (MIC) and minimum bactericidal concentrations (MBC) for a 99% and a 99.9% kill can be reproducibly determined for fosfomycin by the agar dilution procedure when placing the inoculum on top of membrane filters. In 88.7% (85%) of 80 bacterial strains (Enterobacteriaceae, Pseudomonas aeruginosa, Staphylococcus aureus) examined we found a 99% (99.9%) kill at concentrations higher than the respective MIC by up to one dilution step. For 5% (10%), the bactericidal concentrations were more than two steps higher. Both the MIC and the MBC were influenced by the culture medium. The influence of the medium on fosfomycin activity was also shown by the time-kill curves. In nutrient broth, Mueller-Hinton broth, Iso-Sensitest broth and human plasma water (with and without glucose-6-phosphate) we found different killing rates, different killing maxima and different times of regrowth of the cultures. The bactericidal activity of fosfomycin against Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 25923, and Pseudomonas aeruginosa ATCC 27853 was more pronounced in plasma water, nutrient broth, and Mueller-Hinton broth than in Iso-Sensitest broth.


Archive | 1976

Broad spectrum antibacterial hydantoinyl-acetyl-ampicillin derivs. - prepd. by reacting hydantoinyl-acetic acids with phenyl-glycine and (6)-amino-penicillanic acid

Kurt Stach; Gerd Zimmermann; Max Dr Rer Nat Thiel; Wolfgang Dr Med Voemel; Rita Dr Phil Hoffmann


Archive | 1978

Increasing the enteral reabsorption of pharmaceuticals - by administration together with an aminoacid or a peptide

Rainer Haag; Rita Dr Phil Hoffmann; Wolfgang Dr Med Voemel


Archive | 1974

Nitroimidazolyl-triazolo-pyridazine und verfahren zu ihrer herstellung

Herbert Berger; Rudi Gall; Kurt Stach; Wolfgang Dr Med Voemel; Rita Dr Phil Hoffmann


Archive | 1972

Anti-microbial nitroimidazolyl-triazolo-pyridazines - used in pharma-ceuticals, prepd via amination or cyclisation reactions

Herbert Berger; Rudi Gall; Kurt Stach; Wolfgang Dr Med Voemel; Rita Dr Phil Hoffmann


Archive | 1972

Antimicrobial 5-nitro-2-imidazolyl-s-triazolo-pyridazines - prepd by cyclisation of substd imidazol-2-aldehyde and hydrazino-pyridin-chlorohydrate

Herbert Berger; Rudi Gall; Kurt Stach; Wolfgang Dr Med Voemel; Rita Dr Phil Hoffmann


Archive | 1975

Nitroimidazolyl-triazolo-pyridazine compounds and therapeutic compositions

Herbert Berger; Rudi Gall; Kurt Stach; Wolfgang Vomel; Rita Dr Phil Hoffmann


Archive | 1975

Combating bacteria with nitroimidazolyl-triazolo-pyridiazine compounds

Herbert Berger; Rudi Gall; Kurt Stach; Wolfgang Vomel; Rita Dr Phil Hoffmann


Archive | 1973

Nitroimidazolyl-triazolo-pyridazines and process for their preparation

Rudi Gall; Rita Dr Phil Hoffmann; Herbert Berger; Kurt Stach; Wolfgang Vomel


Archive | 1975

Nitroimidazolyl-triazolo-pyridazine compounds

Herbert Berger; Rudi Gall; Kurt Stach; Wolfgang Vomel; Rita Dr Phil Hoffmann

Collaboration


Dive into the Rita Dr Phil Hoffmann's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge